In Practise Logo
In Practise Logo - Blue
In Practise Logo
Partner Interview
Published February 25, 2025

Asseco: M&A Strategy & Pricing Power

Executive Bio

Former Healthcare Director at Asseco Poland

Interview Transcript

Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.

This is a snippet of the transcript.to get full access.

The forward or backward? Could you clarify what you mean by that?

I'm referring to the fact that Asseco, for roughly the past 10 years, has primarily been a platform for acquiring new companies rather than developing their own solutions from scratch. They excel at maintaining their position and are adept at purchasing new companies to expand their portfolio. However, they are not as proficient in developing and broadening their product portfolio. They do not invest heavily in research and development, but rather focus on maintaining their area of expertise or acquiring new companies.

This is a snippet of the transcript.to get full access.

Why were they unable to raise prices back in 2012?

As I mentioned earlier, the barriers to entry are quite high. So, it's really difficult to replace ecosystems if they are already implemented. It's hard to replace them and they're quite good, I believe. That's why.

This is a snippet of the transcript.to get full access.

Why were they unable to raise prices back in 2012?

Especially in the health sector, there is significantly more money now. Hospitals and other practices are able to pay much more than they could eight or 10 years ago. They are able to raise prices, at least in the health sector, but probably also in others.

This is a snippet of the transcript.to get full access.

Free Sample of 50+ Interviews

Sign up to test our content quality with a free sample of 50+ interviews.

Or contact sales for full access

© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.